COLL vs. MGK

In the year-to-date period, COLL achieves a 1.71% return, which is significantly higher than MGK's 0.42% return. Over the past 10 years, COLL has underperformed MGK with an annualized return of 5.21%, while MGK has yielded a comparatively higher 16.06% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and Vanguard Mega Cap Growth ETF (MGK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current COLL Sharpe Ratio is -0.26, which is lower than the MGK Sharpe Ratio of 0.72. The chart below compares the historical Sharpe Ratios of COLL and MGK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

COLL has not paid dividends to shareholders, while MGK's dividend yield for the trailing twelve months is around 0.44%.

The maximum COLL drawdown since its inception was -73.59%, which is greater than MGK's maximum drawdown of -48.36%. Use the drawdown chart below to compare losses from any high point for COLL and MGK.

Collegium Pharmaceutical, Inc. (COLL) has a higher volatility of 9.41% compared to Vanguard Mega Cap Growth ETF (MGK) at 6.01%. This indicates that COLL's price experiences larger fluctuations and is considered to be riskier than MGK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.